Modeling complex genetic and environmental influences on comorbid bipolar disorder with tobacco use disorder

BMC Medical Genetics

Volumn 11, Issue 1, 2010, Pages

  McEachin, Richard C ^a,b   Saccone, Nancy L ^c   Saccone, Scott F ^c   Kleyman Smith, Yelena D ^d   Kar, Tiara ^d   Kare, Rajesh K ^d   Ade, Alex S ^b   Sartor, Maureen A ^b   Cavalcoli, James D ^b   McInnis, Melvin G ^a,b  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

^c WASHINGTON UNIVERSITY   (United States)

^d EASTERN MICHIGAN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; CATECHOL METHYLTRANSFERASE; NICOTINE; SEROTONIN TRANSPORTER; SOLUTE CARRIER FAMILY 6 MEMBER 3; UNCLASSIFIED DRUG; AGENTS INTERACTING WITH TRANSMITTER, HORMONE OR DRUG RECEPTORS; DOPAMINE TRANSPORTER; SLC6A3 PROTEIN, HUMAN; SLC6A4 PROTEIN, HUMAN;

ARTICLE; BIOINFORMATICS; BIPOLAR DISORDER; COMORBIDITY; ENVIRONMENTAL EXPOSURE; GENE EXPRESSION; GENE INTERACTION; GENE REGULATORY NETWORK; GENE REPLICATION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC MODEL; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE ENVIRONMENT INTERACTION; HUMAN; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; THEORY VALIDATION; TOBACCO DEPENDENCE; BIOLOGICAL MODEL; BIOLOGY; ENVIRONMENT; GENETICS; META ANALYSIS; RISK FACTOR;

NICOTIANA TABACUM;

BIPOLAR DISORDER; CATECHOL O-METHYLTRANSFERASE; COMORBIDITY; COMPUTATIONAL BIOLOGY; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; ENVIRONMENT; GENE REGULATORY NETWORKS; HUMANS; MODELS, GENETIC; NEUROTRANSMITTER AGENTS; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; SIGNAL TRANSDUCTION; TOBACCO USE DISORDER;

EID: 76949104315     PISSN: None     EISSN: 14712350     Source Type: Journal    
DOI: 10.1186/1471-2350-11-14     Document Type: Article

References (97)

1. Grant BF, Stinson FS, Hasin DS, Dawson DA, Chou SP, Ruan WJ, Huang B. Prevalence, correlates, and comorbidity of bipolar I disorder and axis I and II disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions. J Clin Psychiatry 2005, 66:1205-1215. 10.4088/JCP.v66n1001, 16259532.
2. Merikangas KR, Akiskal HS, Angst J, Greenberg PE, Hirschfeld RM, Petukhova M, Kessler RC. Lifetime and 12-month prevalence of bipolar spectrum disorder in the National Comorbidity Survey replication. Arch Gen Psychiatry 2007, 64:543-552. 10.1001/archpsyc.64.5.543, 1931566, 17485606.
3. Finney Rutten LJ, Augustson EM, Moser RP, Beckjord EB, Hesse BW. Smoking knowledge and behavior in the United States: sociodemographic, smoking status, and geographic patterns. Nicotine Tob Res 2008, 10:1559-1570. 10.1080/14622200802325873, 18946775.
4. Carmelli D, Swan GE, Robinette D, Fabsitz R. Genetic influence on smoking--a study of male twins. N Engl J Med 1992, 327:829-833.
5. Vanable PA, Carey MP, Carey KB, Maisto SA. Smoking among psychiatric outpatients: relationship to substance use, diagnosis, and illness severity. Psychol Addict Behav 2003, 17:259-265. 10.1037/0893-164X.17.4.259, 2440500, 14640821.
6. MeSH. , http://www.ncbi.nlm.nih.gov/sites/entrez?db=mesh
7. Carney CP, Jones LE. Medical comorbidity in women and men with bipolar disorders: a population-based controlled study. Psychosom Med 2006, 68:684-691. 10.1097/01.psy.0000237316.09601.88, 17012521.
8. Hughes JR, Hatsukami DK, Mitchell JE, Dahlgren LA. Prevalence of smoking among psychiatric outpatients. Am J Psychiatry 1986, 143:993-997.
9. Gonzalez-Pinto A, Gutierrez M, Ezcurra J, Aizpuru F, Mosquera F, Lopez P, de Leon J. Tobacco smoking and bipolar disorder. J Clin Psychiatry 1998, 59:225-228.
10. Lasser K, Boyd JW, Woolhandler S, Himmelstein DU, McCormick D, Bor DH. Smoking and mental illness: A population-based prevalence study. Jama 2000, 284:2606-2610. 10.1001/jama.284.20.2606, 11086367.
11. Ucok A, Polat A, Bozkurt O, Meteris H. Cigarette smoking among patients with schizophrenia and bipolar disorders. Psychiatry Clin Neurosci 2004, 58:434-437. 10.1111/j.1440-1819.2004.01279.x, 15298658.
12. Wilens TE, Biederman J, Adamson JJ, Henin A, Sgambati S, Gignac M, Sawtelle R, Santry A, Monuteaux MC. Further evidence of an association between adolescent bipolar disorder with smoking and substance use disorders: a controlled study. Drug Alcohol Depend 2008, 95:188-198. 10.1016/j.drugalcdep.2007.12.016, 2365461, 18343050.
13. Burmeister M, McInnis MG, Zollner S. Psychiatric genetics: progress amid controversy. Nat Rev Genet 2008, 9:527-540. 10.1038/nrg2381, 18560438.
14. Lerman CE, Schnoll RA, Munafo MR. Genetics and smoking cessation improving outcomes in smokers at risk. Am J Prev Med 2007, 33:S398-405. 10.1016/j.amepre.2007.09.006, 2170888, 18021915.
15. McGuffin P, Rijsdijk F, Andrew M, Sham P, Katz R, Cardno A. The heritability of bipolar affective disorder and the genetic relationship to unipolar depression. Arch Gen Psychiatry 2003, 60:497-502. 10.1001/archpsyc.60.5.497, 12742871.
16. Edvardsen J, Torgersen S, Roysamb E, Lygren S, Skre I, Onstad S, Oien PA. Heritability of bipolar spectrum disorders. Unity or heterogeneity?. J Affect Disord 2008, 106:229-240. 10.1016/j.jad.2007.07.001, 17692389.
17. Bertelsen A, Harvald B, Hauge M. A Danish twin study of manic-depressive disorders. Br J Psychiatry 1977, 130:330-351. 10.1192/bjp.130.4.330, 558030.
18. Li MD, Cheng R, Ma JZ, Swan GE. A meta-analysis of estimated genetic and environmental effects on smoking behavior in male and female adult twins. Addiction 2003, 98:23-31. 10.1046/j.1360-0443.2003.00295.x, 12492752.
19. Lerman C, Berrettini W. Elucidating the role of genetic factors in smoking behavior and nicotine dependence. Am J Med Genet B Neuropsychiatr Genet 2003, 118B:48-54. 10.1002/ajmg.b.10003, 12627466.
20. Bax L, Yu LM, Ikeda N, Tsuruta H, Moons KG. Development and validation of MIX: comprehensive free software for meta-analysis of causal research data. BMC Med Res Methodol 2006, 6:50. 10.1186/1471-2288-6-50, 1626481, 17038197.
21. Bax L YL, Ikeda N, Tsuruta H, Moons KGM. MIX: comprehensive free software for meta-analysis of causal research data. Book MIX: comprehensive free software for meta-analysis of causal research data. (Editor ed.^eds.), Version 1.7 edition. City 2008,
22. Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, Moher D, Becker BJ, Sipe TA, Thacker SB. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. Jama 2000, 283:2008-2012. 10.1001/jama.283.15.2008, 10789670.
23. Gene2MeSH. , http://gene2mesh.ncibi.org
24. McEachin RC, Keller BJ, Zandi PP, Almani M, McInnis MG. Prioritizing Disease Genes by Analysis of Common Elements (PDG-ACE). AMIA Annu Symp Proc 2007, 1068.
25. Keller BJ, McEachin RC. Identifying hypothetical genetic influences on complex disease phenotypes. BMC Bioinformatics 2009, 10(Suppl 2):S13. 10.1186/1471-2105-10-S2-S13, 2646236, 19208188.
26. Raychaudhuri S, Plenge RM, Rossin EJ, Ng AC, Purcell SM, Sklar P, Scolnick EM, Xavier RJ, Altshuler D, Daly MJ. Identifying relationships among genomic disease regions: predicting genes at pathogenic SNP associations and rare deletions. PLoS Genet 2009, 5:e1000534. 10.1371/journal.pgen.1000534, 2694358, 19557189.
27. Tarcea VG, Weymouth T, Ade A, Bookvich A, Gao J, Mahavisno V, Wright Z, Chapman A, Jayapandian M, Ozgur A, et al. Michigan molecular interactions r2: from interacting proteins to pathways. Nucleic Acids Res 2009, 37:D642-646. 10.1093/nar/gkn722, 2686565, 18978014.
28. von Mering C, Huynen M, Jaeggi D, Schmidt S, Bork P, Snel B. STRING: a database of predicted functional associations between proteins. Nucleic Acids Res 2003, 31:258-261. 10.1093/nar/gkg034, 165481, 12519996.
29. von Mering C, Jensen LJ, Kuhn M, Chaffron S, Doerks T, Kruger B, Snel B, Bork P. STRING 7--recent developments in the integration and prediction of protein interactions. Nucleic Acids Res 2007, 35:D358-362. 10.1093/nar/gkl825, 1669762, 17098935.
30. Ekins S, Nikolsky Y, Bugrim A, Kirillov E, Nikolskaya T. Pathway mapping tools for analysis of high content data. Methods Mol Biol 2007, 356:319-350.
31. Gao J, Ade AS, Tarcea VG, Weymouth TE, Mirel BR, Jagadish HV, States DJ. Integrating and annotating the interactome using the MiMI plugin for cytoscape. Bioinformatics 2009, 25:137-138. 10.1093/bioinformatics/btn501, 2638934, 18812364.
32. Becker KG, Barnes KC, Bright TJ, Wang SA. The genetic association database. Nat Genet 2004, 36:431-432. 10.1038/ng0504-431, 15118671.
33. Dennis G, Sherman BT, Hosack DA, Yang J, Gao W, Lane HC, Lempicki RA. DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol 2003, 4:P3. 10.1186/gb-2003-4-5-p3, 12734009.
34. Huang da W, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 2009, 4:44-57. 10.1038/nprot.2008.211, 19131956.
35. Sartor MA, Mahavisno V, Keshamouni VG, Cavalcoli J, Wright Z, Karnovsky A, Kuick R, Jagadish HV, Mirel B, Weymouth T, et al. ConceptGen: a gene set enrichment and gene set relation mapping tool. Bioinformatics 2009,
36. Edgar R, Domrachev M, Lash AE. Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res 2002, 30:207-210. 10.1093/nar/30.1.207, 99122, 11752295.
37. Sartor MA, Tomlinson CR, Wesselkamper SC, Sivaganesan S, Leikauf GD, Medvedovic M. Intensity-based hierarchical Bayes method improves testing for differentially expressed genes in microarray experiments. BMC Bioinformatics 2006, 7:538. 10.1186/1471-2105-7-538, 1781470, 17177995.
38. Saccone SF, Saccone NL, Swan GE, Madden PA, Goate AM, Rice JP, Bierut LJ. Systematic biological prioritization after a genome-wide association study: an application to nicotine dependence. Bioinformatics 2008, 24:1805-1811. 10.1093/bioinformatics/btn315, 2610477,2610477, 18565990.
39. Bierut LJ, Madden PA, Breslau N, Johnson EO, Hatsukami D, Pomerleau OF, Swan GE, Rutter J, Bertelsen S, Fox L, et al. Novel genes identified in a high-density genome wide association study for nicotine dependence. Hum Mol Genet 2007, 16:24-35. 10.1093/hmg/ddl441, 2278047, 17158188.
40. Saccone SF, Hinrichs AL, Saccone NL, Chase GA, Konvicka K, Madden PA, Breslau N, Johnson EO, Hatsukami D, Pomerleau O, et al. Cholinergic nicotinic receptor genes implicated in a nicotine dependence association study targeting 348 candidate genes with 3713 SNPs. Hum Mol Genet 2007, 16:36-49. 10.1093/hmg/ddl438, 2270437, 17135278.
41. Smith EN, Bloss CS, Badner JA, Barrett T, Belmonte PL, Berrettini W, Byerley W, Coryell W, Craig D, Edenberg HJ, et al. Genome-wide association study of bipolar disorder in European American and African American individuals. Mol Psychiatry 2009, 14:755-763. 10.1038/mp.2009.43, 19488044.
42. Beuten J, Payne TJ, Ma JZ, Li MD. Significant association of catechol-O-methyltransferase (COMT) haplotypes with nicotine dependence in male and female smokers of two ethnic populations. Neuropsychopharmacology 2006, 31:675-684. 10.1038/sj.npp.1300997, 16395295.
43. Colilla S, Lerman C, Shields PG, Jepson C, Rukstalis M, Berlin J, DeMichele A, Bunin G, Strom BL, Rebbeck TR. Association of catechol-O-methyltransferase with smoking cessation in two independent studies of women. Pharmacogenet Genomics 2005, 15:393-398. 10.1097/01213011-200506000-00004, 1262648, 15900212.
44. Enoch MA, Waheed JF, Harris CR, Albaugh B, Goldman D. Sex differences in the influence of COMT Val158Met on alcoholism and smoking in plains American Indians. Alcohol Clin Exp Res 2006, 30:399-406. 10.1111/j.1530-0277.2006.00045.x, 16499480.
45. Munafo MR, Johnstone EC, Guo B, Murphy MF, Aveyard P. Association of COMT Val108/158Met genotype with smoking cessation. Pharmacogenet Genomics 2008, 18:121-128. 10.1097/FPC.0b013e3282f44daa, 18192898.
46. Burdick KE, Funke B, Goldberg JF, Bates JA, Jaeger J, Kucherlapati R, Malhotra AK. COMT genotype increases risk for bipolar I disorder and influences neurocognitive performance. Bipolar Disord 2007, 9:370-376. 10.1111/j.1399-5618.2007.00384.x, 17547583.
47. Shifman S, Bronstein M, Sternfeld M, Pisante A, Weizman A, Reznik I, Spivak B, Grisaru N, Karp L, Schiffer R, et al. COMT: a common susceptibility gene in bipolar disorder and schizophrenia. Am J Med Genet B Neuropsychiatr Genet 2004, 128B:61-64. 10.1002/ajmg.b.30032, 15211633.
48. Erblich J, Lerman C, Self DW, Diaz GA, Bovbjerg DH. Effects of dopamine D2 receptor (DRD2) and transporter (SLC6A3) polymorphisms on smoking cue-induced cigarette craving among African-American smokers. Mol Psychiatry 2005, 10:407-414. 10.1038/sj.mp.4001588, 15381926.
49. Ling D, Niu T, Feng Y, Xing H, Xu X. Association between polymorphism of the dopamine transporter gene and early smoking onset: an interaction risk on nicotine dependence. J Hum Genet 2004, 49:35-39. 10.1007/s10038-003-0104-5, 14685824.
50. O'Gara C, Stapleton J, Sutherland G, Guindalini C, Neale B, Breen G, Ball D. Dopamine transporter polymorphisms are associated with short-term response to smoking cessation treatment. Pharmacogenet Genomics 2007, 17:61-67.
51. Segman RH, Kanyas K, Karni O, Lerer E, Goltser-Dubner T, Pavlov V, Lerer B. Why do young women smoke? IV. Role of genetic variation in the dopamine transporter and lifetime traumatic experience. Am J Med Genet B Neuropsychiatr Genet 2007, 144B:533-540. 10.1002/ajmg.b.30507, 17427187.
52. Stapleton JA, Sutherland G, O'Gara C. Association between dopamine transporter genotypes and smoking cessation: a meta-analysis. Addict Biol 2007, 12:221-226. 10.1111/j.1369-1600.2007.00058.x, 17508996.
53. Greenwood TA, Alexander M, Keck PE, McElroy S, Sadovnick AD, Remick RA, Kelsoe JR. Evidence for linkage disequilibrium between the dopamine transporter and bipolar disorder. Am J Med Genet 2001, 105:145-151. 10.1002/1096-8628(2001)9999:9999<::AID-AJMG1161>3.0.CO;2-8, 11304827.
54. Greenwood TA, Schork NJ, Eskin E, Kelsoe JR. Identification of additional variants within the human dopamine transporter gene provides further evidence for an association with bipolar disorder in two independent samples. Mol Psychiatry 2006, 11:125-133. 115, 10.1038/sj.mp.4001764, 16261167.
55. Keikhaee MR, Fadai F, Sargolzaee MR, Javanbakht A, Najmabadi H, Ohadi M. Association analysis of the dopamine transporter (DAT1)-67A/T polymorphism in bipolar disorder. Am J Med Genet B Neuropsychiatr Genet 2005, 135B:47-49. 10.1002/ajmg.b.30174, 15768394.
56. Mick E, Kim JW, Biederman J, Wozniak J, Wilens T, Spencer T, Smoller JW, Faraone SV. Family based association study of pediatric bipolar disorder and the dopamine transporter gene (SLC6A3). Am J Med Genet B Neuropsychiatr Genet 2008, 147B:1182-1185. 10.1002/ajmg.b.30745, 18361424.
57. Ohadi M, Keikhaee MR, Javanbakht A, Sargolzaee MR, Robabeh M, Najmabadi H. Gender dimorphism in the DAT1-67 T-allele homozygosity and predisposition to bipolar disorder. Brain Res 2007, 1144:142-145. 10.1016/j.brainres.2007.01.067, 17316573.
58. Gerra G, Garofano L, Zaimovic A, Moi G, Branchi B, Bussandri M, Brambilla F, Donnini C. Association of the serotonin transporter promoter polymorphism with smoking behavior among adolescents. Am J Med Genet B Neuropsychiatr Genet 2005, 135B:73-78. 10.1002/ajmg.b.30173, 15806583.
59. Kremer I, Bachner-Melman R, Reshef A, Broude L, Nemanov L, Gritsenko I, Heresco-Levy U, Elizur Y, Ebstein RP. Association of the serotonin transporter gene with smoking behavior. Am J Psychiatry 2005, 162:924-930. 10.1176/appi.ajp.162.5.924, 15863794.
60. Anguelova M, Benkelfat C, Turecki G. A systematic review of association studies investigating genes coding for serotonin receptors and the serotonin transporter: I. Affective disorders. Mol Psychiatry 2003, 8:574-591. 10.1038/sj.mp.4001328, 12851635.
61. Cho HJ, Meira-Lima I, Cordeiro Q, Michelon L, Sham P, Vallada H, Collier DA. Population-based and family-based studies on the serotonin transporter gene polymorphisms and bipolar disorder: a systematic review and meta-analysis. Mol Psychiatry 2005, 10:771-781. 10.1038/sj.mp.4001663, 15824745.
62. Lasky-Su JA, Faraone SV, Glatt SJ, Tsuang MT. Meta-analysis of the association between two polymorphisms in the serotonin transporter gene and affective disorders. Am J Med Genet B Neuropsychiatr Genet 2005, 133B:110-115. 10.1002/ajmg.b.30104, 15578606.
63. Mynett-Johnson L, Kealey C, Claffey E, Curtis D, Bouchier-Hayes L, Powell C, McKeon P. Multimarkerhaplotypes within the serotonin transporter gene suggest evidence of an association with bipolar disorder. Am J Med Genet 2000, 96:845-849. 10.1002/1096-8628(20001204)96:6<845::AID-AJMG30>3.0.CO;2-R, 11121194.
64. Alsobrook JP, Zohar AH, Leboyer M, Chabane N, Ebstein RP, Pauls DL. Association between the COMT locus and obsessive-compulsive disorder in females but not males. Am J Med Genet 2002, 114:116-120. 10.1002/ajmg.10040, 11840516.
65. Baca-Garcia E, Vaquero C, Diaz-Sastre C, Saiz-Ruiz J, Fernandez-Piqueras J, de Leon J. A gender-specific association between the serotonin transporter gene and suicide attempts. Neuropsychopharmacology 2002, 26:692-695. 10.1016/S0893-133X(01)00394-3, 11927194.
66. Baud P, Courtet P, Perroud N, Jollant F, Buresi C, Malafosse A. Catechol-O-methyltransferase polymorphism (COMT) in suicide attempters: a possible gender effect on anger traits. Am J Med Genet B Neuropsychiatr Genet 2007, 144B:1042-1047. 10.1002/ajmg.b.30541, 17510945.
67. Beaver KM, Wright JP, DeLisi M. Delinquent peer group formation: evidence of a gene × environment correlation. J Genet Psychol 2008, 169:227-244. 10.3200/GNTP.169.3.227-244, 18788325.
68. Denys D, Van Nieuwerburgh F, Deforce D, Westenberg H. Association between the dopamine D2 receptor TaqI A2 allele and low activity COMT allele with obsessive-compulsive disorder in males. Eur Neuropsychopharmacol 2006, 16:446-450. 10.1016/j.euroneuro.2005.12.001, 16427255.
69. Domschke K, Deckert J, O'Donovan MC, Glatt SJ. Meta-analysis of COMT val158met in panic disorder: ethnic heterogeneity and gender specificity. Am J Med Genet B Neuropsychiatr Genet 2007, 144B:667-673. 10.1002/ajmg.b.30494, 17357147.
70. Eley TC, Tahir E, Angleitner A, Harriss K, McClay J, Plomin R, Riemann R, Spinath F, Craig I. Association analysis of MAOA and COMT with neuroticism assessed by peers. Am J Med Genet B Neuropsychiatr Genet 2003, 120B:90-96. 10.1002/ajmg.b.20046, 12815746.
71. Galeeva AR, Gareeva AE, Iur'ev EB, Khusnutdinova EK. [VNTR polymorphisms of the serotonin transporter and dopamine transporter genes in male opiate addicts]. Mol Biol (Mosk) 2002, 36:593-598.
72. Kim SJ, Kim YS, Kim SY, Lee HS, Kim CH. An association study of catechol-O-methyltransferase and monoamine oxidase A polymorphisms and personality traits in Koreans. Neurosci Lett 2006, 401:154-158. 10.1016/j.neulet.2006.03.006, 16584839.
73. Lee HK. Association of the serotonin transporter gene polymorphism with Korean male alcoholics. Nihon Arukoru Yakubutsu Igakkai Zasshi 2007, 42:602-604.
74. Lin JJ, Yueh KC, Chang DC, Chang CY, Yeh YH, Lin SZ. The homozygote 10-copy genotype of variable number tandem repeat dopamine transporter gene may confer protection against Parkinson's disease for male, but not to female patients. J Neurol Sci 2003, 209:87-92. 10.1016/S0022-510X(03)00002-9, 12686408.
75. Mandelli L, Serretti A, Marino E, Pirovano A, Calati R, Colombo C. Interaction between serotonin transporter gene, catechol-O-methyltransferase gene and stressful life events in mood disorders. Int J Neuropsychopharmacol 2007, 10:437-447. 10.1017/S1461145706006882, 16756688.
76. Olsson CA, Anney RJ, Lotfi-Miri M, Byrnes GB, Williamson R, Patton GC. Association between the COMT Val158Met polymorphism and propensity to anxiety in an Australian population-based longitudinal study of adolescent health. Psychiatr Genet 2005, 15:109-115. 10.1097/00041444-200506000-00007, 15900225.
77. Ono H, Shirakawa O, Nushida H, Ueno Y, Maeda K. Association between catechol-O-methyltransferase functional polymorphism and male suicide completers. Neuropsychopharmacology 2004, 29:1374-1377. 10.1038/sj.npp.1300470, 15127078.
78. Sookoian S, Gianotti TF, Gemma C, Burgueno A, Pirola CJ. Contribution of the functional 5-HTTLPR variant of the SLC6A4 gene to obesity risk in male adults. Obesity (Silver Spring) 2008, 16:488-491. 10.1038/oby.2007.64, 18239665.
79. Jorgensen E, Stinson A, Shan L, Yang J, Gietl D, Albino AP. Cigarette smoke induces endoplasmic reticulum stress and the unfolded protein response in normal and malignant human lung cells. BMC Cancer 2008, 8:229. 10.1186/1471-2407-8-229, 2527015, 18694499.
80. Strakowski SM, DelBello MP. The co-occurrence of bipolar and substance use disorders. Clin Psychol Rev 2000, 20:191-206. 10.1016/S0272-7358(99)00025-2, 10721497.
81. Singh MK, DelBello MP, Kowatch RA, Strakowski SM. Co-occurrence of bipolar and attention-deficit hyperactivity disorders in children. Bipolar Disord 2006, 8:710-720. 10.1111/j.1399-5618.2006.00391.x, 17156157.
82. McClernon FJ, Kollins SH. ADHD and smoking: from genes to brain to behavior. Ann N Y Acad Sci 2008, 1141:131-147. 10.1196/annals.1441.016, 2758663, 18991955.
83. Berrettini W, Yuan X, Tozzi F, Song K, Francks C, Chilcoat H, Waterworth D, Muglia P, Mooser V. Alpha-5/alpha-3 nicotinic receptor subunit alleles increase risk for heavy smoking. Mol Psychiatry 2008, 13:368-373. 10.1038/sj.mp.4002154, 2507863, 18227835.
84. Thorgeirsson TE, Stefansson K. Genetics of smoking behavior and its consequences: the role of nicotinic acetylcholine receptors. Biol Psychiatry 2008, 64:919-921. 10.1016/j.biopsych.2008.09.010, 19000575.
85. Thorgeirsson TE, Geller F, Sulem P, Rafnar T, Wiste A, Magnusson KP, Manolescu A, Thorleifsson G, Stefansson H, Ingason A, et al. A variant associated with nicotine dependence, lung cancer and peripheral arterial disease. Nature 2008, 452:638-642. 10.1038/nature06846, 18385739.
86. Cooper RG. Effect of tobacco smoking on renal function. Indian J Med Res 2006, 124:261-268.
87. Raedler TJ, Wiedemann K. Lithium-induced nephropathies. Psychopharmacol Bull 2007, 40:134-149.
88. Waterreus AJ, Laugharne JD. Screening for the metabolic syndrome in patients receiving antipsychotic treatment: a proposed algorithm. Med J Aust 2009, 190:185-189.
89. Grippo AJ, Johnson AK. Stress, depression and cardiovascular dysregulation: a review of neurobiological mechanisms and the integration of research from preclinical disease models. Stress 2009, 12:1-21. 10.1080/10253890802046281, 2613299, 19116888.
90. O'Keane V. Antipsychotic-induced hyperprolactinaemia, hypogonadism and osteoporosis in the treatment of schizophrenia. J Psychopharmacol 2008, 22:70-75. 10.1177/0269881107088439, 18477623.
91. Clark L, Sahakian BJ. Cognitive neuroscience and brain imaging in bipolar disorder. Dialogues Clin Neurosci 2008, 10:153-163.
92. Kenney JW, Gould TJ. Modulation of hippocampus-dependent learning and synaptic plasticity by nicotine. Mol Neurobiol 2008, 38:101-121. 10.1007/s12035-008-8037-9, 2683366, 18690555.
93. Berk M, Dodd S, Kauer-Sant'anna M, Malhi GS, Bourin M, Kapczinski F, Norman T. Dopamine dysregulation syndrome: implications for a dopamine hypothesis of bipolar disorder. Acta Psychiatr Scand Suppl 2007, 41-49. 10.1111/j.1600-0447.2007.01058.x, 17688462.
94. Quik M, O'Leary K, Tanner CM. Nicotine and Parkinson's disease: implications for therapy. Mov Disord 2008, 23:1641-1652. 10.1002/mds.21900, 18683238.
95. McIntyre RS, Nguyen HT, Soczynska JK, Lourenco MT, Woldeyohannes HO, Konarski JZ. Medical and substance-related comorbidity in bipolar disorder: translational research and treatment opportunities. Dialogues Clin Neurosci 2008, 10:203-213.
96. Goodnick PJ, Chaudry T, Artadi J, Arcey S. Women's issues in mood disorders. Expert Opin Pharmacother 2000, 1:903-916. 10.1517/14656566.1.5.903, 11249499.
97. Franklin TR, Ehrman R, Lynch KG, Harper D, Sciortino N, O'Brien CP, Childress AR. Menstrual cycle phase at quit date predicts smoking status in an NRT treatment trial: a retrospective analysis. J Womens Health (Larchmt) 2008, 17:287-292. 10.1089/jwh.2007.0423, 18321180.